Results 181 to 190 of about 9,793 (303)

Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 9, Page 1779-1813, May 2026.
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos   +16 more
wiley   +1 more source

Real-world quality of life in patients with hereditary angioedema receiving lanadelumab or other long-term prophylaxis. [PDF]

open access: yesAllergy Asthma Proc
Davis-Lorton M   +8 more
europepmc   +1 more source

Romosozumab‐Associated Recurrent Erythema Nodosum in Mixed Connective Tissue Disease

open access: yesACR Open Rheumatology, Volume 8, Issue 4, April 2026.
Objective The aim of this study was to describe recurrent erythema nodosum (EN) temporally associated with romosozumab in a patient with mixed connective tissue disease and to examine the biologic plausibility of this association in the context of Wnt/β‐catenin–mediated immune regulation.
Jose Luis Diaz Macip   +5 more
wiley   +1 more source

Screening for Plasminogen Mutations in Hereditary Angioedema Patients. [PDF]

open access: yesGenes (Basel), 2021
Farkas H   +4 more
europepmc   +1 more source

Role of Endothelial G Protein-Coupled Receptor Kinase 2 in Angioedema [PDF]

open access: bronze, 2020
Jessica Gambardella   +18 more
openalex   +1 more source

Pellagra From Tryptophan Depletion in Carcinoid Syndrome due to a Pulmonary Atypical Carcinoid Neuroendocrine Tumor

open access: yesClinical Case Reports, Volume 14, Issue 4, April 2026.
ABSTRACT Pellagra may complicate functioning pulmonary atypical carcinoid and present as a subtle acral dermatosis rather than the classical photo‐distributed rash. In neuroendocrine tumor patients with chronic diarrhea and new skin changes, clinicians should suspect niacin deficiency and consider empiric nicotinamide, even when niacin assays are ...
Ahmar Iftikhar Talib   +2 more
wiley   +1 more source

Rethinking the management of hereditary angioedema. [PDF]

open access: yesAllergy Asthma Proc
Busse P   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy